⌘K

07:56:26·480d

SECFilingvia Quantisnow

SEC Form S-8 POS filed by Singular Genomics Systems Inc.

ByQuantisnow·Wall Street's wire, on your screen.

OMIC· Singular Genomics Systems Inc.

Industrials

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Large owner Tang Kevin returned 372,000 shares to the company (SEC Form 4)
Singular Genomics Systems Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Material Modification to Rights of Security Holders, Changes in Control of Registrant
Amendment: SEC Form SCHEDULE 13D/A filed by Singular Genomics Systems Inc.
Chief Executive Officer Spaventa Andrew returned 143,310 shares to the company, closing all direct ownership in the company (SEC Form 4)
Chief Financial Officer Meeter Dalen returned 9,502 shares to the company, closing all direct ownership in the company (SEC Form 4)